175 related articles for article (PubMed ID: 21871802)
41. Gastric metastasis of breast cancer: a single centre retrospective study.
Almubarak MM; Laé M; Cacheux W; de Cremoux P; Pierga JY; Reyal F; Bennett SP; Falcou MC; Salmon RJ; Baranger B; Mariani P
Dig Liver Dis; 2011 Oct; 43(10):823-7. PubMed ID: 21616731
[TBL] [Abstract][Full Text] [Related]
42. The effect of delays in treatment for breast cancer metastasis on survival.
Jung SY; Sereika SM; Linkov F; Brufsky A; Weissfeld JL; Rosenzweig M
Breast Cancer Res Treat; 2011 Dec; 130(3):953-64. PubMed ID: 21739101
[TBL] [Abstract][Full Text] [Related]
43. [A retrospective analysis of clinic-pathological characteristics and prognostic factor for 137 cases of breast cancer brain metastasis].
Gao YC; Liu H; Lu S; Zhuang XR; Wang YX; Wang T; Wu YY; Chen MX
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):30-4. PubMed ID: 23578424
[TBL] [Abstract][Full Text] [Related]
44. Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs.
Hurvitz SA; O'Shaughnessy J; Mason G; Yardley DA; Jahanzeb M; Brufsky A; Rugo HS; Swain SM; Kaufman PA; Tripathy D; Chu L; Li H; Antao V; Cobleigh M
Clin Cancer Res; 2019 Apr; 25(8):2433-2441. PubMed ID: 30593513
[TBL] [Abstract][Full Text] [Related]
45. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
[TBL] [Abstract][Full Text] [Related]
46. CNS metastases in breast cancer patients: prognostic implications of tumor subtype.
Bachmann C; Schmidt S; Staebler A; Fehm T; Fend F; Schittenhelm J; Wallwiener D; Grischke E
Med Oncol; 2015 Jan; 32(1):400. PubMed ID: 25433950
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
[TBL] [Abstract][Full Text] [Related]
48. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.
Lin NU; Claus E; Sohl J; Razzak AR; Arnaout A; Winer EP
Cancer; 2008 Nov; 113(10):2638-45. PubMed ID: 18833576
[TBL] [Abstract][Full Text] [Related]
49. Cranial magnetic resonance imaging in the staging of HER2-positive Breast Cancer Patients.
Kaplan MA; Inal A; Kucukoner M; Urakci Z; Ekici F; Firat U; Zincircioglu SB; Isikdogan A
Onkologie; 2013; 36(4):176-81. PubMed ID: 23548965
[TBL] [Abstract][Full Text] [Related]
50. Characteristics of breast cancer patients with central nervous system metastases: a single-center experience.
Harputluoglu H; Dizdar O; Aksoy S; Kilickap S; Dede DS; Ozisik Y; Guler N; Barista I; Gullu I; Hayran M; Selek U; Cengiz M; Zorlu F; Tekuzman G; Altundag K
J Natl Med Assoc; 2008 May; 100(5):521-6. PubMed ID: 18507204
[TBL] [Abstract][Full Text] [Related]
51. Central nervous system metastases in breast cancer.
Kiricuta IC; Kölbl O; Willner J; Bohndorf W
J Cancer Res Clin Oncol; 1992; 118(7):542-6. PubMed ID: 1624546
[TBL] [Abstract][Full Text] [Related]
52. Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
Laakmann E; Witzel I; Fasching PA; Rezai M; Schem C; Solbach C; Tesch H; Klare P; Schneeweiss A; Salat C; Zahm DM; Blohmer JU; Ingold-Heppner B; Huober J; Hanusch C; Jackisch C; Reinisch M; Untch M; von Minckwitz G; Nekljudova V; Müller V; Loibl S
Breast Cancer Res; 2019 May; 21(1):60. PubMed ID: 31077239
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
Masci G; Agostinetto E; Giordano L; Bottai G; Torrisi R; Losurdo A; De Sanctis R; Navarria P; Scorsetti M; Zuradelli M; de Rose F; Bello L; Santoro A
Future Oncol; 2020 Mar; 16(7):269-279. PubMed ID: 32043375
[No Abstract] [Full Text] [Related]
54. The shifting landscape of metastatic breast cancer to the CNS.
Quigley MR; Fukui O; Chew B; Bhatia S; Karlovits S
Neurosurg Rev; 2013 Jul; 36(3):377-82. PubMed ID: 23262837
[TBL] [Abstract][Full Text] [Related]
55. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.
Miller KD; Weathers T; Haney LG; Timmerman R; Dickler M; Shen J; Sledge GW
Ann Oncol; 2003 Jul; 14(7):1072-7. PubMed ID: 12853349
[TBL] [Abstract][Full Text] [Related]
56. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
[TBL] [Abstract][Full Text] [Related]
57. Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases.
Higashi H; Fukutomi T; Watanabe T; Adachi I; Narabayashi M; Shibui S; Hokamura N; Akashi-Tanaka S
Breast Cancer; 2000; 7(2):153-6. PubMed ID: 11029788
[TBL] [Abstract][Full Text] [Related]
58. Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry.
van den Hurk CJ; Eckel R; van de Poll-Franse LV; Coebergh JW; Nortier JW; Hölzel D; Breed WP; Engel J
Breast Cancer Res Treat; 2011 Aug; 128(3):795-805. PubMed ID: 21311969
[TBL] [Abstract][Full Text] [Related]
59. Central nervous system metastases in breast cancer: the impact of age on patterns of development and outcome.
Ben-Zion Berliner M; Yerushalmi R; Lavie I; Benouaich-Amiel A; Tsoref D; Hendler D; Goldvaser H; Sarfaty M; Rotem O; Ulitsky O; Siegal T; Neiman V; Yust-Katz S
Breast Cancer Res Treat; 2021 Jan; 185(2):423-432. PubMed ID: 33037977
[TBL] [Abstract][Full Text] [Related]
60. Risk factors for central nervous system metastasis in patients with metastatic breast cancer.
Sezgin C; Gokmen E; Esassolak M; Ozdemir N; Goker E
Med Oncol; 2007; 24(2):155-61. PubMed ID: 17848738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
